Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer

The role of RANKL-RANK pathway in progesterone-driven mammary carcinogenesis and triple negative breast cancer tumorigenesis has been well characterized. However, and despite evidences of the existence of RANK-positive hormone receptor (HR)-positive breast tumors, the implication of RANK expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Inês, de Almeida, Bernardo P., Dâmaso, Sara, Mansinho, André, Correia, Inês, Henriques, Sara, Cruz-Duarte, Raquel, Vilhais, Guilherme, Félix, Pedro, Alves, Patrícia, Corredeira, Patrícia, Barbosa-Morais, Nuno L., Costa, Luis, Casimiro, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233807/
https://www.ncbi.nlm.nih.gov/pubmed/32477461
http://dx.doi.org/10.18632/oncotarget.27576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233807/
https://www.ncbi.nlm.nih.gov/pubmed/32477461
http://dx.doi.org/10.18632/oncotarget.27576

Ejemplares similares